News
QGEN
49.89
-0.42%
-0.21
AFM Discloses Voting-Rights Notification for QIAGEN
TipRanks · 11h ago
Massachusetts Financial Services Company Reports 2.89% QIAGEN Voting-Rights Holding
TipRanks · 11h ago
QIAGEN Reports AFM Disclosure of UBS Group Voting Rights
TipRanks · 11h ago
Qiagen Price Target Raised to $50.00/Share From $48.00 by UBS
Dow Jones · 15h ago
Qiagen Is Maintained at Neutral by UBS
Dow Jones · 15h ago
UBS Maintains Neutral on Qiagen, Raises Price Target to $50
Benzinga · 15h ago
Qiagen price target raised to $50 from $48 at UBS
TipRanks · 19h ago
Qiagen (QGEN) Stock Looks Reasonable Following Precision Medicine Program News
Simply Wall St · 1d ago
Why Is Qiagen (QGEN) Central To The Growing RNA Extraction Kits Market?
Simply Wall St · 2d ago
Bank of America Reports 5.50% QIAGEN Stake
TipRanks · 3d ago
AFM Register Reports T. Rowe Price’s 3.03% QIAGEN Interest
TipRanks · 3d ago
T. Rowe Price Group Reports 2.98% Capital Interest in QIAGEN
TipRanks · 3d ago
AFM Publishes BlackRock Voting Rights Notification for Qiagen
TipRanks · 3d ago
Amundi Notification Reports 3.25% Capital Interest in QIAGEN
TipRanks · 3d ago
AFM Register Records UBS Group’s 5.46% QIAGEN Capital Interest
TipRanks · 3d ago
AFM Discloses BlackRock Voting-Rights Notification for Qiagen
TipRanks · 3d ago
AFM Discloses UBS Group Voting-Rights Notification for Qiagen
TipRanks · 3d ago
Weekly Report: what happened at QGEN last week (1102-1106)?
Weekly Report · 4d ago
Qiagen shareholders approve Jonathan Pratt as managing director
TipRanks · 11/06 15:11
QIAGEN N.V. Reports Q3 2026 Results and Suspends Outlook Pending Acquisition by EQT Private Equity
NASDAQ · 11/06 13:31
More
Webull provides a variety of real-time QGEN stock news. You can receive the latest news about Qiagen through multiple platforms. This information may help you make smarter investment decisions.
About QGEN
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.